Citius Oncology, Inc. Financial Flexibility Index
Citius Oncology, Inc. financial flexibility index. Citius Oncology, Inc. (CTOR) has a Financial Flexibility Index of -0.01x as of June 2026. Free cash flow of $-848.44K (operating CF $-2.85 Million minus capex $2.00 Million) represents 0% of total liabilities ($71.71 Million). See cash generation quality of Citius Oncology, Inc. to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Citius Oncology, Inc. (2022–2025)
Financial flexibility index of Citius Oncology, Inc. from 2022 to 2025. Historical Financial Flexibility Index trend for Citius Oncology, Inc. across 4 annual periods. Check CTOR cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Citius Oncology, Inc. Financial Flexibility Index by Year (2022–2025)
Citius Oncology, Inc. financial flexibility index by year from 2022 to 2025. Year-by-year free cash flow to debt coverage for Citius Oncology, Inc.. For the full cash flow conversion analysis, see Citius Oncology, Inc. cash flow conversion.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.10x | $-5.49 Million | $-5.49 Million | $56.08 Million | ▼ -3063.1% |
| 2024 | 0.00x | $126.36K | $126.35K | $38.23 Million | ▲ +112.2% |
| 2023 | -0.03x | $-601.30K | $-601.30K | $22.20 Million | ▼ -262.7% |
| 2022 | -0.01x | $-47.97K | $-47.97K | $6.42 Million | — |